JTJake P. Taylor-King

Jake P. Taylor-King

*This is an algorithmically generated author record based on publicly available information.

Jake P. Taylor-King has a total of 251 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Scalable variant-to-function screens using prime editing perturb-seq

    by Joachim De Jonghe, Magdalena Armas Reyes, Catriona Jamieson, Jens Bager Christensen, James W. Opzoomer, Jake P. Taylor-King

    Linking genetic variants to their functional consequences at scale remains a major challenge in human genetics. Perturb-seq is limited in the variants it can install, while prime editing has largely been restricted to simpler mechanistic readouts. Here, we introduce prime editing perturb-seq (PEP-seq), which links programmed mutations to transcriptomic states. We designed 2,164 prime editing guides targeting common expression quantitative trait loci (eQTLs), premature termination codons, and position-matched synonymous controls, generating 749,110 time-resolved single-cell transcriptomes. PEP-seq precisely detected nonsense-mediated decay, while probe-based junction measurements suggested depletion of mature RNAs. For eQTLs, a locus-size-corrected specificity metric showed that the intended target was frequently the most affected transcript within a 1 Mb window, with effects also associated with open chromatin near the edit site. These results establish PEP-seq as a scalable platform for direct, endogenous variant-to-function mapping.

  • Open Access

    Multiscale analysis and functional validation of the cellular and genetic determinants of skeletal disease

    by Ryan C. Chai, Mischa Lundberg, Bernard Freudenthal, James T. Smith, Andrew P. Boughton, Yuandan Zhang, Kaitlyn A. Flynn, Monika Frysz, Alexander P. Corr, Weng Hua Khoo, et al.

    Musculoskeletal diseases are a major health burden. Development of bone-active therapies has been hindered by limited understanding of the cells and genes that regulate the skeleton. We exploited the value of cross-species analysis and developed single-cell methodologies in skeletal tissues to define the critical endosteal compartment that regulates bone turnover. Thirty-four distinct cell types were identified, and disease-relevant cells prioritized using enrichment for rare skeletal disorder genes and bone-mineral-density-associated genes in an extended UK Biobank genome-wide association study. Functional validation was undertaken in over 1,000 genetically modified mouse models. Endothelial cells and vascular smooth muscle cells were identified as new skeletal-disease-relevant cells alongside osteoblast, chondrocyte and osteoclast cell lineages. Hundreds of cell-specific genes with unappreciated roles in skeletal pathophysiology were identified. This comprehensive cellular and molecular framework underpins skeletal physiology and disease and will help prioritize new therapeutic targets to accelerate development of therapies to treat musculoskeletal disease.


  • Open Access

    Identification of epigenetic regulators of fibrotic transformation in cardiac fibroblasts through bulk and single-cell CRISPR screens

    by Laura Pilar Aguado-Alvaro, Nerea Garitano, Wolfgang Esser-Skala, Judy Sayers, Cynthia del Valle, Daniel Alameda, Julen Mendieta-Esteban, Maria Erendira Calleja-Cervantes, Ainhoa Goñi-Salaverri, Jon Zazpe, et al.

    Cardiac fibrosis is mediated by the persistent activity of myofibroblasts, which differentiates from resident cardiac fibroblasts in response to tissue damage and stress signals. The signaling pathways and transcription factors regulating fibrotic transformation have been thoroughly studied. In contrast, the roles of chromastin factors in myofibroblast differentiation and their contribution to pathogenic cardiac fibrosis remain poorly understood. Here, we combined bulk and single-cell CRISPR screens to characterize the roles of chromatin factors in the fibrotic transformation of primary cardiac fibroblasts. We uncover strong regulators of fibrotic states including Srcap and Kat5 chromatin remodelers. We confirm that these factors are required for functional processes underlying fibrosis including collagen synthesis and cell contractility. Using chromatin profiling in perturbed cardiac fibroblasts, we demonstrate that pro-fibrotic chromatin complexes facilitate the activity of well-characterized pro-fibrotic transcription factors. Finally, we show that KAT5 inhibition alleviates fibrotic responses in patient-derived human fibroblasts.


  • Open Access

    When three experiments are better than two: Avoiding intractable correlated aleatoric uncertainty by leveraging a novel bias--variance tradeoff

    by Paul Scherer, Andreas Kirsch, Jake P. Taylor-King

    Real-world experimental scenarios are characterized by the presence of heteroskedastic aleatoric uncertainty, and this uncertainty can be correlated in batched settings. The bias--variance tradeoff can be used to write the expected mean squared error between a model distribution and a ground-truth random variable as the sum of an epistemic uncertainty term, the bias squared, and an aleatoric uncertainty term. We leverage this relationship to propose novel active learning strategies that directly reduce the bias between experimental rounds, considering model systems both with and without noise. Finally, we investigate methods to leverage historical data in a quadratic manner through the use of a novel cobias--covariance relationship, which naturally proposes a mechanism for batching through an eigendecomposition strategy. When our difference-based method leveraging the cobias--covariance relationship is utilized in a batched setting (with a quadratic estimator), we outperform a number of canonical methods including BALD and Least Confidence.

  • Open Access

    Identification of Epigenetic Regulators of Fibrotic Transformation in Cardiac Fibroblasts Through Bulk and Single-Cell CRISPR Screens

    by Laura Pilar Aguado Álvaro, Nerea Garitano, Wolfgang Esser-Skala, Judy Sayers, Cynthia del Valle, Daniel Alameda-Serrano, Julen Mendieta-Esteban, Maria Erendira Calleja-Cervantes, Ainhoa Goñi-Salaverri, Jon Zazpe, et al.

    Cardiac fibrosis is mediated by the persistent activity of myofibroblasts, which differentiate from resident cardiac fibroblasts in response to tissue damage and stress signals. The signaling pathways and transcription factors regulating fibrotic transformation have been thoroughly studied. In contrast, the roles of chromatin factors in myofibroblast differentiation and their contribution to pathogenic cardiac fibrosis remain poorly understood. Here, we combined bulk and single-cell CRISPR screens to characterize the roles of chromatin factors in the fibrotic transformation of primary cardiac fibroblasts. We uncover strong regulators of fibrotic states including Srcap and Kat5 chromatin remodelers. We confirm that these factors are required for functional processes underlying fibrosis including collagen synthesis and cell contractility. Using chromatin profiling in perturbed cardiac fibroblasts, we demonstrate that pro-fibrotic chromatin complexes facilitate the activity of well-characterized pro-fibrotic transcription factors. Finally, we show that KAT5 inhibition alleviates fibrotic responses in patient-derived human fibroblasts.

  • Open Access

    No Foundations without Foundations -- Why semi-mechanistic models are essential for regulatory biology

    by Luka Kovačević, Thomas Gaudelet, James Opzoomer, Hagen Triendl, John Whittaker, Caroline Uhler, Lindsay Edwards, Jake P. Taylor-King

    Despite substantial efforts, deep learning has not yet delivered a transformative impact on elucidating regulatory biology, particularly in the realm of predicting gene expression profiles. Here, we argue that genuine "foundation models" of regulatory biology will remain out of reach unless guided by frameworks that integrate mechanistic insight with principled experimental design. We present one such ground-up, semi-mechanistic framework that unifies perturbation-based experimental designs across both in vitro and in vivo CRISPR screens, accounting for differentiating and non-differentiating cellular systems. By revealing previously unrecognised assumptions in published machine learning methods, our approach clarifies links with popular techniques such as variational autoencoders and structural causal models. In practice, this framework suggests a modified loss function that we demonstrate can improve predictive performance, and further suggests an error analysis that informs batching strategies. Ultimately, since cellular regulation emerges from innumerable interactions amongst largely uncharted molecular components, we contend that systems-level understanding cannot be achieved through structural biology alone. Instead, we argue that real progress will require a first-principles perspective on how experiments capture biological phenomena, how data are generated, and how these processes can be reflected in more faithful modelling architectures.


  • Open Access

    scTrends: A living review of commercial single-cell and spatial 'omic technologies

    by Joachim De Jonghe, James W Opzoomer, Amaia Vilas-Zornoza, Benedikt S Nilges, Peter Crane, Marco Vicari, Hower Lee, David Lara-Astiaso, Torsten Gross, Jörg Morf, et al.


  • A community effort to track commercial single-cell and spatial ’omic technologies and business trends

    by Joachim De Jonghe, James W. Opzoomer, Amaia Vilas-Zornoza, Peter Crane, Benedikt S. Nilges, Marco Vicari, Hower Lee, David Lara-Astiaso, Torsten Gross, Jörg Morf, et al.


  • Top Cited Papers

    scPerturb: harmonized single-cell perturbation data

    by Stefan Peidli, Tessa D. Green, Ciyue Shen, Torsten Gross, Joseph Min, Samuele Garda, Bo Yuan, Linus J. Schumacher, Jake P. Taylor-King, Debora S. Marks, et al.

    Analysis across a growing number of single-cell perturbation datasets is hampered by poor data interoperability. To facilitate development and benchmarking of computational methods, we collect a set of 44 publicly available single-cell perturbation–response datasets with molecular readouts, including transcriptomics, proteomics and epigenomics. We apply uniform quality control pipelines and harmonize feature annotations. The resulting information resource, scPerturb, enables development and testing of computational methods, and facilitates comparison and integration across datasets. We describe energy statistics (E-statistics) for quantification of perturbation effects and significance testing, and demonstrate E-distance as a general distance measure between sets of single-cell expression profiles. We illustrate the application of E-statistics for quantifying similarity and efficacy of perturbations. The perturbation–response datasets and E-statistics computation software are publicly available at scperturb.org. This work provides an information resource for researchers working with single-cell perturbation data and recommendations for experimental design, including optimal cell counts and read depth.


  • Open Access

    The Future of Machine Learning Within Target Identification: Causality, Reversibility, and Druggability

    by Jake P. Taylor‐King, Michael Bronstein, David Roblin